Puma Biotechnology Stock Target Price and Analyst Consensus

PBYI Stock  USD 3.39  0.16  4.95%   
The current analyst and expert consensus on Puma Biotechnology is Hold, with no strong buy opinions. The current projected Puma Biotechnology target price consensus is 5.00 with 3 analyst opinions. Check out Macroaxis Advice on Puma Biotechnology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.
The most common way Puma Biotechnology analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Puma Biotechnology executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Puma Biotechnology. We encourage you to use your own analysis of Puma Biotechnology to validate this buy or sell advice. Puma Biotechnology buy-or-sell recommendation module provides average expert sentiment on the projected Puma Biotechnology target price to derive its highest and lowest estimates based on projected price volatility of 4.3178.
Lowest Forecast
4.55
Highest Forecast
5.55
Target Price
5
The Puma Biotechnology's current Gross Profit Margin is estimated to increase to 0.88, while Gross Profit is projected to decrease to under 101.1 M. As of now, Puma Biotechnology's Non Currrent Assets Other are increasing as compared to previous years. The Puma Biotechnology's current Inventory is estimated to increase to about 8.2 M, while Total Assets are projected to decrease to under 165.1 M.
  
It's important to approach Puma Biotechnology's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Puma Biotechnology price targets

Puma Biotechnology's stock target price is an estimate of its future price, usually made by analysts. Using Puma Biotechnology's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Puma Biotechnology's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Puma Biotechnology's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Puma Biotechnology Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Puma Biotechnology is a key component of Puma Biotechnology valuation and have some predictive power on the future returns of a Puma Biotechnology.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Puma Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.173.377.69
Details
Intrinsic
Valuation
LowRealHigh
0.193.888.20
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.120.120.13
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Momentum Idea
Momentum
Invested few shares
Video Games Idea
Video Games
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 200 shares
Power Assets Idea
Power Assets
Invested over 200 shares
ESG Investing Idea
ESG Investing
Invested few shares
FinTech Idea
FinTech
Invested over 40 shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
When determining whether Puma Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Puma Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puma Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puma Biotechnology Stock:
Check out Macroaxis Advice on Puma Biotechnology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.